3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
2
Neoplasms
2
Stomach Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Breath Test
1
Breast Neoplasms
1
Barrett Esophagus
1
Interventions
Blood Specimen Collection
38
pembrolizumab
36
Bevacizumab
22
Surveys and Questionnaires
18
Standard of Care
18
Radiotherapy
18
Exercise
17
Carboplatin
16
Nivolumab
15
atezolizumab
14
Cisplatin
14
Drug Therapy
13
Paclitaxel
12
Fluorouracil
12
Cyclophosphamide
12
Cetuximab
12
Trastuzumab
10
Leucovorin
10
Docetaxel
10
Dexamethasone
10
Pemetrexed
9
Oxaliplatin
9
Biopsy
9
pertuzumab
8
olaparib
8
Temozolomide
8
Panitumumab
8
Observation
8
Irinotecan
8
abemaciclib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms
×
Breath Tests
×
Clear all
NCT05427136
2026-05-08
SWISS-Pearl
University Children's Hospital Basel
Recruiting
140 enrolled
NCT06346054
2026-02-17
MAGEC
KU Leuven
Phase NA
Recruiting
1,000 enrolled